The most common pattern of biomarkers is triple negative (ER‐, PR‐, and HER2‐) in ductal carcinoma, comprising 33.3% (10/30 cases) of the cases with reported biomarkers. The gene discussed is ERBB2; the disease is breast ductal adenocarcinoma.